About Hubrecht Organoid Technology (HUB)

Hubrecht Organoid Technology (HUB) is a not-for-profit company founded by the Hubrecht Institute, the Royal Netherlands Academy of Arts and Sciences (KNAW) and the University Medical Center Utrecht, The Netherlands. HUB Organoid Technology is a paradigm-shifting platform for drug discovery and development, companion diagnostics, and (pre)clinical patient stratification. HUB  exploits the pioneering work of Prof. Dr. Hans Clevers who discovered methods to grow stem cell-derived human epithelial tissue from tissues of patients with various diseases into ‘mini-organs’ (organoids).


We are looking for people with imagination and ambition. Smart people who want to make a difference using their abilities. We offer a dynamic, international, and world-leading working environment. At HUB we focus on growth, recognition, diversity, and the empowerment of our employees to help us take HUB into the future.



Scientist Cystic Fibrosis About HUB: Hubrecht Organoid Technology (HUB) is a biot... read more